{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2014"],"condition":["Colorectal Cancer Stage IV","Colorectal Neoplasms"],"disease":["Colorectal Cancer Stage Iv","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2203395"],"location":["Italy"],"study_start_month":["4"],"keyword":["Chemotherapy","Metabolic response","PET"],"repository":["ECRIN MDR"],"study_status":["Active, not recruiting"],"additional_accession":[]},"is_claimable":false,"name":"PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment","description":"The purpose of this study is to test whether an early metabolic response, measured by PET/CT scan after the first cycle of chemotherapy, is able to predict which patients with advanced CRC have a better prognosis.","dates":{"creation":"2014-04-15"},"accession":"2203395","cross_references":{"ClinicalTrials___gov":["NCT02618850"]}}